Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
10.
Rev Med Chir Soc Med Nat Iasi ; 86(1): 57-61, 1982.
Artigo em Romano | MEDLINE | ID: mdl-25591251

RESUMO

Out of 205 children, former patients with viral hepatitis, investigated after the end of the follow-up period by clinical and laboratory examinations, 9 (4.4%) presented mild or moderate pathological alterations. At the second control, carried out after an another interval de 1-1½ years, the pathological alterations were refound only in 2 of the former patients, suggesting that all the others presented lasting forms of acute viral hepatitis evolving towards healing. The presence of AgHBs and the alteration of proteinogramme in the acute phase of VH can serve as criteria of unfavourable prognosis of the disease evolution and impose a preferential follow-up of this category of patients.


Assuntos
Alanina Transaminase/sangue , Aspartato Aminotransferases/sangue , Antígenos de Superfície da Hepatite B/sangue , Antígenos E da Hepatite B/sangue , Hepatite B Crônica/diagnóstico , Hepatite B Crônica/virologia , Adolescente , Biomarcadores/sangue , Criança , Pré-Escolar , Feminino , Seguimentos , Hepatite B/complicações , Hepatite B Crônica/sangue , Hepatomegalia/virologia , Humanos , Lactente , Masculino , Índice de Gravidade de Doença , Esplenomegalia/virologia
12.
Artigo em Romano | MEDLINE | ID: mdl-141081

RESUMO

A group of 39 former dysentery patients, who continued to excrete Shigella bacteria after a first cure of antibiotics when full clinical recovery was obtained, were treated differentially under bacteriological control. The carrier state was still extent in 7% of the cases after three antibiotic or chemotherapeutical cures. No direct relation was found between the sensitivity of Shigella to chemotherapeutics and the level of the carrier state. Although treated already in the acute stage with adequate antibiotics, resistance to a second therapeutical attempt was recorded in a proportion of 33%. It is considered useless to repeat the antibiotic or chemotherapeutical cures in the treatment of convalescent carriers because of the low efficiency and the biological and economical disadvantages.


Assuntos
Antibacterianos/uso terapêutico , Disenteria Bacilar/tratamento farmacológico , Adolescente , Adulto , Antibacterianos/administração & dosagem , Portador Sadio/tratamento farmacológico , Criança , Pré-Escolar , Convalescença , Análise Custo-Benefício , Humanos , Lactente , Pessoa de Meia-Idade , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...